StockData
BullFrog AI Holdings, Inc. logo

BullFrog AI Holdings, Inc. (BFRGW) stock

BFRGWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.12+0.02 (+18.00%)

Close on Oct 30, 2026Market cap $9.04MP/E –Yield –

BullFrog AI Holdings, Inc. reported revenue of $116.67K for fiscal 2025. At the latest close the market valued the company at $9.04M.

Revenue
$116.67K
FY2025
Operating income
-$6.10M
TTM Q2 2026
EPS, diluted
-$0.47
TTM Q2 2026

Key statistics

Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026

Valuation

Market cap
$9.04M
P/E ratio
–
Price to sales
–
Price to book
1.29
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$116.67K
Net income
-$6.00M
EPS, diluted
-$0.47
Book value per share
$0.37
Diluted shares
19M

Trading

Previous close
$0.10
Open
$0.10
Day's range
$0.10 – $0.12
Volume
8,456
Average volume (20 days)
13,968
Beta (5 years)
3.19
52-week range
$0.43 – $1.96
RSI (14 days)
42.5
Volatility (1 year)
168.2%
Relative volume
0.03×
WACC
17.5%

Market cap history

Month-end market cap since 2023, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

PeriodBFRGWS&P 500DifferenceBFRGW per yearS&P 500 per year
1 month-19.7%-0.9%−18.8 pts
3 months+7.3%+2.1%+5.1 pts
Year to date-38.2%+11.7%−49.9 pts
1 year-71.2%+12.4%−83.6 pts
3 years-78.9%+88.6%−167.5 pts-40.5%+23.5%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

–

Gross profit

–

Operating income

-$6.10M

Net income

-$6.00M

EPS, diluted

-$0.47

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases BullFrog AI filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About BullFrog AI

Pharmaceutical Preparations

BullFrog AI Holdings, Inc. operates as a digital healthcare and artificial intelligence company focused on advancing biopharmaceutical development. The company utilizes its proprietary bfLEAP™ artificial intelligence and machine learning platform, derived from technology developed at The Johns Hopkins University Applied Physics Laboratory, to analyze complex pre-clinical and clinical data sets. Its business model centers on contract services, providing fee-for-service analytics to biopharmaceutical firms and other organizations, as well as collaborative arrangements and the internal development of acquired drug assets targeting various oncology and liver disease indications.

Company profile, executives and history

BullFrog AI stock: common questions

What is BullFrog AI's stock price?

BFRGW closed at $0.12 on Oct 30, 2026, up 18.00% on the day. Over the past 52 weeks it traded between $0.43 and $1.96.

What is BullFrog AI's market cap?

BullFrog AI was worth $9.04M at the close on Oct 30, 2026: the share price times the diluted shares outstanding.

What is BFRGW's P/E ratio?

BullFrog AI lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.47), so it has no meaningful P/E ratio.

How much revenue does BullFrog AI make?

BullFrog AI reported revenue of $116.67K for fiscal 2025.

Does BullFrog AI pay a dividend?

No. BullFrog AI has not paid a cash dividend over the last twelve months.

How has BFRGW stock performed over the past year?

Including dividends, BFRGW returned -71.2% over the past year, against +12.4% for the S&P 500.

Who are BullFrog AI's competitors?

Companies most similar to BullFrog AI by business, industry and size include LNAI, LSTA, HIND, LEXX, IXHL.